Funder
National Institute on Aging
Publisher
Springer Science and Business Media LLC
Reference45 articles.
1. Macchiarini F, Miller RA, Strong R, Rosenthal N, Harrison DE. NIA interventions testing program: a collaborative approach for investigating interventions to promote healthy aging. In: Musi N, Hornsby PJ, editors. Handbook of the Biology of Aging. 9th ed. London (UK): Academic Press; 2021.
2. Harrison DE, Strong R, Reifsnyder P, Rosenthal N, Korstanje R, Fernandez E, et al. Astaxanthin and meclizine extend lifespan in UM-HET3 male mice; fisetin, SG1002 (hydrogen sulfide donor), dimethyl fumarate, mycophenolic acid, and 4-phenylbutyrate do not significantly affect lifespan in either sex at the doses and schedules used. Geroscience. 2023;46(1):795–816.
3. Miller RA, Harrison DE, Allison DB, Bogue M, Debarba L, Diaz V, et al. Canagliflozin extends life span in genetically heterogeneous male but not female mice. JCI Insight. 2020;5(21):e140019. https://doi.org/10.1172/jci.insight.140019.
4. Snyder JM, Casey KM, Galecki A, Harrison DE, Jayarathne H, Kumar N, et al. Canagliflozin retards age-related lesions in heart, kidney, liver, and adrenal gland in genetically heterogenous male mice. Geroscience. 2022;45(1):385–97.
5. Strong R, Miller RA, Antebi A, Astle CM, Bogue M, Denzel MS, et al. Longer lifespan in male mice treated with a weakly estrogenic agonist, an antioxidant, an alpha-glucosidase inhibitor or a Nrf2-inducer. Aging Cell. 2016;15(5):872–84.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献